Chemical approaches to development of mitochondrial-targeted Hsp90 inhibitor in anti-cancer therapeutics: Mechanism and structure change of mitochondrial Hsp90

被引：0
|
作者：
Hu, Sung
Yoon, Nam Gu
Kang, Byoung Heon
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1492
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1492
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas
    Wei, Shiyou
    Yin, Delong
    Yu, Shengnan
    Lin, Xiang
    Savani, Milan R.
    Du, Kuang
    Ku, Yin
    Wu, Di
    Li, Shasha
    Liu, Hao
    Tian, Meng
    Chen, Yaohui
    Bowie, Michelle
    Hariharan, Seethalakshmi
    Waitkus, Matthew
    Keir, Stephen T.
    Sugarman, Eric T.
    Deek, Rebecca A.
    Labrie, Marilyne
    Khasraw, Mustafa
    Lu, Yiling
    Mills, Gordon B.
    Herlyn, Meenhard
    Wu, Kongming
    Liu, Lunxu
    Wei, Zhi
    Flaherty, Keith T.
    Abdullah, Kalil
    Zhang, Gao
    Ashley, David M.
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (10) : 2180 - 2195
  • [2] Hsp90 as an anti-cancer target
    Neckers, L
    Mimnaugh, E
    Schulte, TW
    [J]. DRUG RESISTANCE UPDATES, 1999, 2 (03) : 165 - 172
  • [3] A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy
    Bryant, Kelly G.
    Chae, Young Chan
    Martinez, Rogelio L.
    Gordon, John C.
    Elokely, Khaled M.
    Kossenkov, Andrew V.
    Grant, Steven
    Childers, Wayne E.
    Abou-Gharbia, Magid
    Altieri, Dario C.
    [J]. ONCOTARGET, 2017, 8 (68) : 112184 - 112198
  • [4] Mitochondrial-targeted Hsp90 C-terminal inhibitors manifest anti-proliferative activity
    Zhang, Zheng
    Banerjee, Monimoy
    Davis, Rachel E.
    Blagg, Brian S. J.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (22)
  • [5] Clinical and biological significances of heat shock protein 90 (Hsp90) in human nasopharyngeal carcinoma cells and anti-cancer effects of Hsp90 inhibitor
    Liu, Fangxian
    Wang, Liangliang
    Yi, Shijiang
    Liu, Qianghe
    Xu, Xiaoxiao
    Su, Min
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2019, 120
  • [6] Effectiveness of Hsp90 inhibitors as anti-cancer drugs
    Xiao, Li
    Lu, Xiangyi
    Ruden, Douglas M.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (10) : 1137 - 1143
  • [7] Binding Mechanism of Anti-Cancer Target HSP90 and Peptide Drug
    Matsukura, Lisa
    Miyashita, Naoyuki
    [J]. BIOPHYSICAL JOURNAL, 2020, 118 (03) : 512A - 512A
  • [8] Landscape of the mitochondrial Hsp90 metabolome in tumours
    Young Chan Chae
    Alessia Angelin
    Sofia Lisanti
    Andrew V. Kossenkov
    Kaye D. Speicher
    Huan Wang
    James F. Powers
    Arthur S. Tischler
    Karel Pacak
    Stephanie Fliedner
    Ryan D. Michalek
    Edward D. Karoly
    Douglas C. Wallace
    Lucia R. Languino
    David W. Speicher
    Dario C. Altieri
    [J]. Nature Communications, 4
  • [9] TRAP-1, the mitochondrial Hsp90
    Altieri, Dario C.
    Stein, Gary S.
    Lian, Jane B.
    Languino, Lucia R.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2012, 1823 (03): : 767 - 773
  • [10] Landscape of the mitochondrial Hsp90 metabolome in tumours
    Chae, Young Chan
    Angelin, Alessia
    Lisanti, Sofia
    Kossenkov, Andrew V.
    Speicher, Kaye D.
    Wang, Huan
    Powers, James F.
    Tischler, Arthur S.
    Pacak, Karel
    Fliedner, Stephanie
    Michalek, Ryan D.
    Karoly, Edward D.
    Wallace, Douglas C.
    Languino, Lucia R.
    Speicher, David W.
    Altieri, Dario C.
    [J]. NATURE COMMUNICATIONS, 2013, 4
12345